Rici Healthcare Holdings Limited
HKEX:1526.HK
1.18 (HKD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,992.689 | 2,375.027 | 2,377.207 | 1,925.19 | 1,726.206 | 1,373.936 | 1,080.149 | 935.383 | 802.796 | 597.75 | 488.919 |
| Cost of Revenue
| 1,743.18 | 1,447.825 | 1,401.99 | 1,344.526 | 1,242.224 | 987.733 | 678.995 | 581.252 | 522.753 | 408.808 | 323.922 |
| Gross Profit
| 1,249.509 | 927.202 | 975.217 | 580.664 | 483.982 | 386.203 | 401.154 | 354.131 | 280.043 | 188.942 | 164.997 |
| Gross Profit Ratio
| 0.418 | 0.39 | 0.41 | 0.302 | 0.28 | 0.281 | 0.371 | 0.379 | 0.349 | 0.316 | 0.337 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 223.845 | 222.413 | 219.136 | 294.154 | 305.449 | 328.917 | 292.718 | 200.676 | 151.528 | 116.882 | 70.894 |
| Selling & Marketing Expenses
| 380.584 | 286.843 | 252.206 | 226.319 | 237.575 | 225.014 | 175.324 | 76.35 | 67.613 | 42.507 | 27.967 |
| SG&A
| 604.429 | 505.812 | 471.342 | 519.133 | 543.024 | 553.931 | 468.142 | 277.126 | 219.241 | 159.389 | 98.861 |
| Other Expenses
| -11.84 | -3.177 | 11.348 | 7.905 | 8.206 | 0.829 | 0.257 | 0.771 | 0 | 1.11 | -5.324 |
| Operating Expenses
| 592.589 | 483.38 | 466.54 | 530.349 | 504.868 | 532.19 | 491.194 | 243.523 | 208.422 | 153.905 | 93.537 |
| Operating Income
| 656.92 | 431.948 | 520.697 | 76.358 | -41.898 | -155.252 | -56.89 | 90.991 | 73.771 | 33.223 | 71.391 |
| Operating Income Ratio
| 0.22 | 0.182 | 0.219 | 0.04 | -0.024 | -0.113 | -0.053 | 0.097 | 0.092 | 0.056 | 0.146 |
| Total Other Income Expenses Net
| -111.288 | -104.488 | -124.304 | -184.603 | -140.809 | -20.495 | -51.242 | -0.009 | -23.698 | -27.29 | -22.563 |
| Income Before Tax
| 545.632 | 327.19 | 392.075 | -108.823 | -168.248 | -175.747 | -108.914 | 90.982 | 49.587 | 5.933 | 48.828 |
| Income Before Tax Ratio
| 0.182 | 0.138 | 0.165 | -0.057 | -0.097 | -0.128 | -0.101 | 0.097 | 0.062 | 0.01 | 0.1 |
| Income Tax Expense
| 143.657 | 84.041 | 98.373 | 16.326 | 2.25 | 39.47 | 6.234 | 36.593 | 20.471 | 0.265 | 8.974 |
| Net Income
| 363.803 | 290.793 | 349.15 | -7.876 | -69.163 | -53.836 | -62.166 | 58.924 | 28.982 | 8.319 | 36.52 |
| Net Income Ratio
| 0.122 | 0.122 | 0.147 | -0.004 | -0.04 | -0.039 | -0.058 | 0.063 | 0.036 | 0.014 | 0.075 |
| EPS
| 0.23 | 0.17 | 0.22 | -0.005 | -0.044 | -0.034 | -0.039 | 0.044 | 0.02 | 0.005 | 0.023 |
| EPS Diluted
| 0.23 | 0.17 | 0.22 | -0.005 | -0.044 | -0.034 | -0.038 | 0.04 | 0.023 | 0.005 | 0.023 |
| EBITDA
| 1,069.588 | 572.613 | 682.804 | 234.749 | 347.105 | -33.142 | 2.207 | 171.038 | 141.688 | 86.081 | 118.783 |
| EBITDA Ratio
| 0.357 | 0.241 | 0.287 | 0.122 | 0.063 | -0.024 | 0.022 | 0.183 | 0.176 | 0.144 | 0.243 |